ATHX News 2.73 Athersys (ATHX)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Athersys (ATHX) 2.73 $ATHX

Athersys to Host First Quarter 2014 Financial Results Call
GlobeNewswire - Wed Apr 16, 10:30AM CDT
Athersys, Inc. (Nasdaq:ATHX) will release its first quarter 2014 financial results at approximately 4:00 PM (Eastern Time) on Thursday, May 8, 2014, and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehmann, President and Chief Operating Officer, will host the call as follows:

Zacks Rank #5 Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday

Stock to Watch: Athersys Down 5.2% (ATHX)
Comtex SmarTrend(R) - Mon Apr 14, 12:45PM CDT
Athersys (NASDAQ:ATHX) is one of today's worst performing low-priced stocks, down 5.2% to $2.71 on 1.1x average daily volume. Thus far today, Athersys has traded 1.2 million shares, vs. average volume of 1.1 million shares per day. The stock has underperformed the Dow (-5.2% to the Dow's 0.9%) and underperformed the S&P 500 (-5.2% to the S&P's 0.8%) during today's trading.

Zacks Rank #5 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 14, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday

Biotech Stocks Review -- Research on Achillion Pharma, Medivation, Mast Therapeutics, and Athersys
PR Newswire - Mon Apr 14, 7:16AM CDT
On Friday, April 11, 2014, the NASDAQ Composite ended at 3,999.73, down 1.34%, the Dow Jones Industrial Average declined 0.89%, to finish the day at 16,026.75, and the S&P 500 closed at 1,815.69, down 0.95%. The losses were broad based as all the sectors ended the session in negative. The S&P 500 Health Care Sector Index ended the day at 644.74, down 1.07%, and the same has fallen by 2.36% in the previous three months. Investor-Edge has initiated coverage on the following equities: Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), Medivation Inc. (NASDAQ: MDVN), Mast Therapeutics Inc. (NYSE MKT: MSTX) and Athersys Inc. (NASDAQ: ATHX). Free technical research on ACHN, MDVN, MSTX and ATHX can be downloaded upon signing up at:

Zacks Rank #5 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday

Tradable Biotech Stocks Events For the Second Quarter
at The Street - Thu Apr 03, 8:00AM CDT
The biotech sector's March "fluctuation" might be a temporary speed bump or the beginning of a longer downturn. Either way, investors can still count on the biotech catalyst trade for chills and thrills.

Athersys to Present at 2014 BIO Asia International Conference
GlobeNewswire - Wed Mar 26, 1:00PM CDT
Athersys, Inc. (Nasdaq:ATHX) announced today that the Company will present at the 2014 BIO Asia International Conference to be held at the Grand Hyatt in Tokyo, Japan, from April 8-9, 2014.

Zacks Rank #5 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday

MultiStem Overshadows Q4 Loss at Athersys - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 14, 2:31PM CDT
Investor focus is more on Athersys' efforts to develop MultiStem than its earnings report.

Hot Stock: Athersys, Shares Drop 6.0% (ATHX)
Comtex SmarTrend(R) - Fri Mar 14, 10:42AM CDT
Athersys (NASDAQ:ATHX) is one of today's worst performing low-priced stocks, down 6.0% to $3.46 on 1.0x average daily volume. Thus far today, Athersys has traded 1.3 million shares, vs. average volume of 1.2 million shares per day. The stock has underperformed the Dow (-6.0% to the Dow's -0.2%) and underperformed the S&P 500 (-6.0% to the S&P's -0.2%) during today's trading.

Athersys Files Shelf Registration Statement to Replace Prior Shelf
GlobeNewswire - Thu Mar 13, 3:23PM CDT
Athersys, Inc. (Nasdaq:ATHX) announced today that it has filed a shelf registration statement with the U.S. Securities and Exchange Commission ("SEC" . The new shelf registration statement will replace a similar registration statement filed in January 2013. Athersys currently does not have any immediate plans to offer or sell the securities under this registration statement. As with the prior registration statement, the replacement registration statement is intended to provide Athersys with financial flexibility to raise capital, over the next three years, from the offering of up to 20,000,000 shares of common stock and/or warrants. When declared effective, a shelf registration statement gives a company advance regulatory approval to sell securities in one or more separate offerings in amounts and at prices and terms to be determined at the time of the sale.

Athersys Reports Fourth Quarter and 2013 Annual Results
GlobeNewswire - Thu Mar 13, 3:05PM CDT
Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the fourth quarter and year ended December 31, 2013.

Concise Analysis of the United States Regenerative Medicine Market - Forecasts to 2016
M2 - Wed Mar 12, 6:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4lq46f/regenerative) has announced the addition of the "Concise Analysis of the United States Regenerative Medicine Market - Forecasts to 2016" report to their offering. There is a high demand for synthetic organ transplants in the market. Regenerative medicine helps in the development of artificial organs. The introduction of artificial organs for implantation is expected to encourage many vendors and research organizations to develop advanced stem cell products, therapies, and regenerative products. It will also help reduce the long organ waiting list. For instance, custom-made windpipe can be made using regenerative products within a week. The first ever implant of a synthetic trachea took place in June 2011. The synthetic trachea was made from minuscule plastic fibers and was covered in stem cells taken from a human bone marrow. Surgeons successfully implanted this synthetic trachea into a 36-year-old patient with late-stage tracheal cancer at Karolinska University Hospital in Stockholm. Thus, the use of synthetic organs in transplant surgeries is expected to have a positive impact on the growth of the market. According to the report, one of the main drivers of this market is the increasing prevalence of degenerative diseases. Regenerative products have helped in addressing the unmet needs of various disease areas. Another major driver of the market is the significant advances seen in R&D. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Vendor Landscape 8. Buying Criteria 9. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Key Vendor Analysis 15. Other Reports in this Series Companies Mentioned: - Advanced Cell Technology Inc. - Arteriocyte Inc. - Athersys Inc. - Baxter International Inc. - CryoLife - Cytori Therapeutics Inc. - Genzyme Corp. - Geron Corp. - InVivo Therapeutics - Inc. - Integra Life Sciences Holdings Corp. - Kensey Nash Corp. - Kinetic Concepts Inc. - Medtronic Inc. - NeoStem Inc. - Osiris Therapeutics Inc. - Osteotech Inc. - RTI Biologics Inc. - Stryker Corp. - Zimmer Holdings Inc. For more information visit http://www.researchandmarkets.com/research/4l...generative

Global Stem Cell Umbilical Cord Blood (UCB) Market to 2020
M2 - Mon Mar 10, 7:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gsw6jj/global_stem_cell) has announced the addition of the "Global Stem Cell Umbilical Cord Blood (UCB) Market to 2020" report to their offering. The market is expected to reach revenue of $56.4 billion by 2020, growing at CAGR of 33.4% during 2013 to 2020 The study observed that the global umbilical cord blood stem cell market is forecasted to reach market value over $11.5 billion in 2014 from $ 6.5 billion in 2012. Developments and approvals for novel cord blood stem cells therapies is expected to drive the market growth. The storage service market was valued at $7.4 billion in 2013. Increase in prevalence rate of chronic diseases such as cancer, diabetes, blood disease, immune disease, metabolic disease etc. has increased the need of cost effective and efficient way of treatment. However, cord blood stem cells have the potential to treat these chronic diseases effectively. These stem cells have special property of higher cell count in lower blood volume. Collection of these stem cells is much easier than other stem cells and could be stored in specialized preservation facilities called as Cord Blood Stem Cell Banks.Cord blood stem cells market is in its emerging phase. Significant applications of stem cells in the treatment of various disorders will be commercialized very soon as most of them are in the last phase of clinical trials. Patents for collection techniques and therapeutics methods are approved by respective government of developed countries however patents for UCB stem cells are comparatively less in developing economies. According to lead analyst Debbie Shields, the geographic analysis shows that the North American market for cord blood stem cell would account for approx. 44% of total revenue generated by the cord blood market in 2013. However, much expected growth is to occur in Asia-Pacific regions during the forecast period, because of growing demand for chronic disease treatments and widely increasing awareness levels. This report study offers updated review about major market players present in this market such as researcher based pharmaceutical companies and therapeutics services companies. Key Market Segments Global Stem cell UCB market by storage - Public cord blood banks - Private cord blood banks - Public Vs. Private UCB banks Global Stem cell UCB market by Diseases - Cancer/ Oncology diseases - Acute Leukemia - Chronic Leukemia - High Risk Solid Tumors - Myelodysplastic Syndrome - Blood diseases - Aplastic Anemia - Beta Thalassemia - Sickle Cell disease - Immune Disorders - Leukocyte Adhesion Deficiency - Hystiocytic Disorders - Wiskott-Aldrich - Metabolic Disorders - Krabbe Disease - Hurler Syndrome - Sanfilippo Syndrome - Other diseases - Osteopetrosis - Hemophagoyticlymphohistiocytosis Global Stem cell UCB market by Technology - Stem Cell Transplant - Autologous transplant - Allogenic transplant - Transplant Medicine - Regenerative Medicine - Others - Cord Blood Banking - Blood Transfusion - Cell Based Genetics Companies Mentioned - Advanced Cell Technology Inc. (USA) - Athersys Inc. - California Stem Cell - Cytori Therapeutics Inc. - Geron Corporation - Mesoblast Limited - NeoStem Inc. - Opexa Therapeutics Inc. - Osiris Therapeutics - Pluristem Therapeutics Inc. For more information visit http://www.researchandmarkets.com/research/gs..._stem_cell

Athersys to Present at Regen Med Investor Day March 26th in New York
GlobeNewswire - Fri Mar 07, 12:15PM CST
Gil Van Bokkelen, Chairman and Chief Executive Officer of Athersys, Inc. (Nasdaq:ATHX), will present at the second annual Regen Med Investor Day on Wednesday, March 26, 2014 at 1:30 pm (Eastern Time). The conference will be held at the Metropolitan Club in New York City.

Japan's Bold Initiative in Regenerative Medicine and Who the Big Winners Might Be
ACCESSWIRE - Mon Mar 03, 9:55AM CST
Like many other regions in the world, Japan is facing a demographic problem that threatens to pose enormous challenges for their national healthcare system in the years ahead, as the elderly segment of the population expands dramatically. According to analysis by the Ministry of Health Labor and Welfare (MHLW) in Japan, the percentage of the population that is over the age of 65 is expected to nearly double in the coming years. Given that the aging segment of the population requires greater healthcare resources and that this shift will place substantial pressure on the national healthcare system in Japan, it is understandable that the trend has received considerable attention from policy makers.

Athersys to Host Fourth Quarter and Annual Financial Results Call
GlobeNewswire - Tue Feb 25, 9:24AM CST
Athersys, Inc. (Nasdaq:ATHX) will release its 2013 fourth quarter and annual financial results at approximately 4:00 PM EST on Thursday, March 13, 2014, and host a conference call shortly thereafter at 4:30 PM EST to review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehmann, President and Chief Operating Officer, will host the call as follows:

Akpabio - No Apology for Supporting Jonathan [interview]
All Africa Global Media - Thu Feb 13, 4:36AM CST
The Akwa Ibom State Governor, Godswill Akpabio, after paying a courtesy call on the National Chairman of the Peoples Democratic Party, Adamu Mu'azu, pledged his support to the new authority. Chuks Okocha presents excerpts of the session
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Geothermal AI Nodes Take Aim at Stranded Well Power

Updated Category News Views 48

Millions of idle wells are sitting under America like unwanted basement clutter, and GEIOS GEOFLEX thinks some can become small, self-contained AI power plants. That is the provocative idea behind its Dark Token Factory partnership with Aiden Digital Labs: bolt an autonomous compute module onto an abandoned or non-producing oil and gas well, pull geothermal heat from...

Continue Reading
Breakthrough T1D Gala Puts Research Progress First

Updated Category News Views 150

One person living without insulin after a cell-therapy trial is the detail that cuts through all the ballroom polish tonight. Breakthrough T1D's 53rd Annual New York City Promise Gala lands at the Plaza Hotel during National Diabetes Awareness Month, and it carries a message worth handling carefully: research can produce extraordinary outcomes, but one participant's...

Continue Reading
JOYY Q3 Growth Shows More Than Livestreaming Muscle

Updated Category News Views 59

Revenue finally has more than one pair of legs at JOYY, and that matters a whole lot more than a flashy quarterly headline. The company reported third-quarter 2026 revenue of US$624.6 million, up 15.6% from a year earlier and 5.7% from the prior quarter. Those are not microscopic moves, and the composition is the part that deserves the hard stare. JOYY is still rooted in...

Continue Reading
COSCO Shipping Uses CIIE to Put People in the Chain

Updated Category News Views 57

A Supply Chain Is Not Just Steel and Schedules Containers do not shake hands, but the people routing them certainly do. That was the useful, rather human point underneath COSCO SHIPPING's presence at the ninth China International Import Expo in Shanghai: global logistics is a physical business built on relationships that have to survive different languages, markets,...

Continue Reading
IDEMIA Lands Sweden's Critical 5G Connectivity Job

Updated Category News Views 43

A hospital monitor going dark because a device was misprovisioned is not the kind of connectivity hiccup anybody gets to shrug off. That is why IDEMIA Secure Transactions winning the Region Västra Götaland assignment deserves more attention than the usual telecom plumbing announcement. The region is building what it calls Sweden's largest private 5G network, and the job...

Continue Reading
Arbor Realty's Loan Mess Meets a Dividend Shutdown

Updated Category News Views 89

A dividend suspension lands differently when the loan book is already coughing up smoke. Arbor Realty Trust’s latest disclosed numbers are not the sort that investors can shrug off as one ugly quarter and forget by Friday. The company reported a third-quarter 2026 GAAP net loss of $85.4 million, suspended its quarterly cash dividend effective immediately, and described...

Continue Reading
Swell Partners' Awards Highlight Culture, Not Metrics

Updated Category News Views 41

Recognition Lands in a Crowded Talent Market Two shiny Stevie trophies do not pay payroll, but they can say something useful about a company trying to stand out in the noisy talent-services business. Swell Partners has been named 2026 Company of the Year in Business Services and has seen founder and CEO Cari Gatto receive Best Female CEO of the Year. For a private firm...

Continue Reading
Implantica's U.S. Launch Arrives With Cash Still to Burn

Updated Category News Views 77

RefluxStop has finally stepped onto American soil, and that changes the conversation around Implantica in a very real way. FDA Premarket Approval arrived on August 20, then the first U.S. procedures were completed in early November at the University of Southern California. For a small medtech outfit, clearing that regulatory gate and getting actual patients treated are...

Continue Reading
Automotive Laminates: Small Market, Real EV Leverage

Updated Category News Views 126

Cabin trim has become a surprisingly serious battleground, and that is the whole point of this automotive laminates story. Nobody buys a vehicle because somebody bragged about a multilayer film behind the door panel. Yet the materials under the fingertips, beneath the carpet, and around the dashboard increasingly decide whether an interior feels cheap, quiet, durable, or...

Continue Reading
Honda Prelude’s Hybrid Return Tests a Narrow Niche

Updated Category News Views 0

A low-slung coupe showing up in Newfoundland is not exactly a volume-sales thunderclap, and that is precisely why the 2027 Honda Prelude deserves a closer look. Steele Honda in St. John’s is presenting the hybrid two-door as a fresh choice for buyers who want something livelier than the usual practical commuter. For Honda, and for investors watching Honda Motor Co....

Continue Reading

Top 5 Most Recently Viewed Articles

Safety Socket LLC Wins Major Court Ruling Against Counterfeiters

Updated Category News Views 692

Safety Socket LLC Achieves Legal Victory Against Counterfeit Suppliers The jury in a federal court trial has ruled in favor of Safety Socket LLC, confirming that certain fasteners intended for military applications were counterfeit. This significant case, known as Safety Socket LLC v. Relli Technology, Inc., was adjudicated in the U.S. District Court for the Northern...

Continue Reading
Innovative Energy Project Completion in the Gulf of Mexico

Updated Category News Views 244

Completion of McDermott's EPCIC Project in Gulf of Mexico Recently, McDermott celebrated the successful conclusion of its engineering, procurement, construction, installation, and commissioning (EPCIC) project for Shell Offshore Inc., a subsidiary of Shell plc. This project, executed in the Gulf of Mexico, is pivotal in starting oil production at the Whale development....

Continue Reading
Hyperscale Data Plans Major Expansion for AI Infrastructure

Updated Category News Views 365

Significant Power Capacity Increase for Hyperscale Data Hyperscale Data, Inc. (AMEX: GPUS) has recently reported a promising advancement as its subsidiary, Alliance Cloud Services (ACS), has reached a preliminary agreement aimed at boosting the power capacity at its data center. This enhancement, intended to promote growth in artificial intelligence (AI) infrastructure,...

Continue Reading
Global Sewage Crisis Costs $4 Trillion Annually

Updated Category News Views 17

The Overlooked Menace of Sewage Pollution Folks, let me hit you with a harsh reality: while everyone’s chatting about plastic in the ocean or overfishing, there’s a silent disaster slipping under the radar. We’re talking sewage pollution—an issue so vast it's draining the global economy to the tune of $4 trillion each year. That’s what they’re yammering about...

Continue Reading
Inspire Medical Systems, Inc. Class Action Lawsuit Update

Updated Category News Views 231

Inspire Medical Systems, Inc. Investors Take Note The financial landscape for investors is anything but static, particularly for those involved with Inspire Medical Systems, Inc. This article serves as a reminder for investors about the ongoing class action lawsuit, including the critical lead plaintiff deadline. Investors should remain vigilant and informed regarding...

Continue Reading